Therapeutic drug monitoring is associated with better treatment durability among children with inflammatory bowel diseases.
Provider-led I-SNPs have driven down resident hospitalizations, but their effect on other key clinical measures is questionable, a new study shows.
The practice of routinely maintaining PIVC access has not only benefits but also risks. It’s due for a mindset shift, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback